Skip to content

Biochemical Factors for a Dry Eyed Population

Biochemical Factors for a Dry Eyed Population

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00522847
Acronym
GARNET
Enrollment
40
Registered
2007-08-30
Start date
2007-05-31
Completion date
2007-09-30
Last updated
2009-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry Eye

Keywords

Postmenopausal, non dry eye

Brief summary

The purpose of this study is to compare various symptoms and signs of dry-eye as well as stratify characteristics of the tear film in a group of dry-eyed individuals in comparison to a group of non-dry-eyed people. Dry-eye is a condition that significantly impacts the quality of life of the sufferer. These are people who are predominantly female and in the older age groups. Determining what characterises a person with dry-eyes is of importance to understanding the disease process.

Detailed description

Dry eye is a multifactorial disease that results in a wide variety of signs and symptoms, which are often poorly correlated. Recent work has shown that not only are there changes in the composition of the tear film (including cytokines and the presence of various mucin species and tear film proteins) but also quantifiable changes in both the structure and function of the ocular surface, including corneal sensitivity and the appearance of the epithelial cells and the sub-basal neural network. To-date, no published study has attempted to correlate various clinical and morphological changes found in dry eye with tear film and ocular surface biomarkers.

Interventions

None listed

Sponsors

Alcon Research
CollaboratorINDUSTRY
University of Waterloo
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
50 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

A person is eligible for inclusion in the study, for the dry eye group or control, if she: 1. Is Caucasian, and has full legal capacity to volunteer. 2. Is post-menopausal, with menses ceasing more than 12 months ago. 3. Has moderate or severe dry eye symptoms based on dry eye questionnaire and half of the time wants to use eye drops for dry eye symptoms (dry eye group) 4. Has read, understood and signed an information consent letter. 5. Is willing and able to follow instructions and maintain the appointment schedule. 6. Has clear corneas and no active ocular disease. 7. Has had an ocular examination in the last two years.

Exclusion criteria

1. Is on hormone replacement therapy (HRT). 2. Ceased menses due to autoimmune disorders, mumps, chemotherapy, pelvic irradiation or smoking. 3. Has rheumatoid arthritis, diabetes, Sjogren's syndrome or any other systemic disease affecting ocular health. 4. Is using any systemic or topical medications (other than eye drops for dry eye symptoms) that may affect ocular health and neuroendocrine system function. 5. Has undergone corneal refractive surgery. 6. Is aphakic. 7. Has any active ocular disease. 8. Has known sensitivity to the diagnostic pharmaceuticals to be used in the study. 9. Is participating in any other type of clinical or research study. 10. Is a contact lens wearer. 11. Has blepharitis.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026